conjunctivitis%20-%20viral
CONJUNCTIVITIS - VIRAL
Viral conjunctivitis is the inflammation of the conjunctiva of viral etiology.
Signs and symptoms include unilateral or bilateral eye redness, foreign body sensation and follicular conjunctival reaction.
It may be caused by adenovirus, herpes simplex or molluscum contagiosum.
  1. Tabbara KF, Hyndiuk, RA. Infections of the eye. 2nd ed. Boston: Little, Brown and Company; 1996:453-470
  2. Caparas VL, Dy-Liacco JU, Espiritu CG, et al. Handbook of cornea and external diseases: Cornea Club of the Philippines; 2000
  3. Weisbecker CA, Fraunfelder FT, Tipperman R. Physicians' desk reference for ophthalmic medicines. Montvale: Medical Economics Company Inc; 2002
  4. Rhee DJ, Pyfer MF. The Wills eye manual: office and emergency room diagnosis and treatment of eye disease. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1999:121-122
  5. American Academy of Ophthalmology Preferred Practice Patterns Committee Cornea/External Disease Panel. Preferred practice pattern: conjunctivitis. San Francisco: American Academy of Ophthalmology; 2003
  6. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  7. American Academy of Ophthalmology Preferred Practice Patterns Committee Cornea/External Disease Panel. Preferred practice pattern: conjunctivitis. San Francisco: American Academy of Ophthalmology. 2003
  8. Jacobs DS. Conjunctivitis. UpToDate. http://www.uptodate.com/contents/conjunctivitis. 16 Oct 2012. Accessed 14 Feb 2014
  9. American Academy of Ophthalmology Cornea/External Disease PPP Panel, Hoskins Center for Quality Eye Care. Conjunctivitis Summary Benchmark – 2013. ONE Network. http://one.aao.org/summary-benchmark-detail/conjunctivitis-summary-benchmark--october-2012. Oct 2013. Accessed 14 Feb 2014
  10. Alfonso SA, Fawley JD, Lu XA. Conjunctivitis. Primary Care: Clinics in Office Practice. 2015 Sep;42(3):325-345. http://dx.doi.org/10.1016/j.pop.2015.05.001.
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, Yesterday

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 2 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
5 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.